Article Text

Download PDFPDF
Incidence of sexually transmitted infections during pre-exposure prophylaxis for HIV: a worrying outcome at 2 years!
  1. Maïlys Ducours1,
  2. Laure Alleman1,
  3. Mathilde Puges1,
  4. Matthieu Deborde1,
  5. Mojgan Hessamfar1,
  6. Fabien Le-Marec2,
  7. François Dabis1,2,
  8. Sabine Pereyre1,2,
  9. Cécile Bébéar1,2,
  10. Arnaud Descaux1,
  11. Charles Cazanave1,2
  1. 1 Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
  2. 2 Univ. Bordeaux, Bordeaux, France
  1. Correspondence to Dr Charles Cazanave, Centre Hospitalier Universitaire de Bordeaux, Bordeaux 33000, France; charles.cazanave{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data on the occurrence of STIs among men who have sex with men (MSMs) who access pre-exposure prophylaxis (PrEP) in France are lacking, especially about Mycoplasma genitalium (Mgen). We previously reported on the prevalence of STIs in a population who completed 1 year of PrEP at the Bordeaux University Hospital; prevalence of Mgen was 11% (9/89) in this study.1 Here, we report findings from a prospective study conducted in …

View Full Text


  • Handling editor Anna Maria Geretti

  • Collaborators Chloé Le Roy.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval The study was performed with oral informed consent, in accordance with French ethical guidelines (CNIL agreement #2043908).

  • Provenance and peer review Not commissioned; internally peer reviewed.